HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis

NYSE:HIMS • US4330001060

15.82 USD
+0.36 (+2.33%)
At close: Feb 25, 2026
15.7299 USD
-0.09 (-0.57%)
After Hours: 2/25/2026, 8:18:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, HIMS scores 4 out of 10 in our fundamental rating. HIMS was compared to 101 industry peers in the Health Care Providers & Services industry. HIMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. HIMS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HIMS was profitable.
  • HIMS had a positive operating cash flow in the past year.
  • HIMS had negative earnings in 4 of the past 5 years.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.99%, HIMS belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
  • HIMS's Return On Equity of 23.03% is amongst the best of the industry. HIMS outperforms 90.10% of its industry peers.
  • HIMS has a Return On Invested Capital of 5.84%. This is in the better half of the industry: HIMS outperforms 62.38% of its industry peers.
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROIC 5.84%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

  • HIMS has a better Profit Margin (6.05%) than 82.18% of its industry peers.
  • HIMS has a better Operating Margin (5.96%) than 67.33% of its industry peers.
  • With an excellent Gross Margin value of 75.01%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HIMS has grown nicely.
Industry RankSector Rank
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
  • HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.59 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HIMS has a Altman-Z score of 2.59. This is comparable to the rest of the industry: HIMS outperforms 57.43% of its industry peers.
  • HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
  • HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
  • HIMS's Debt to Equity ratio of 1.67 is on the low side compared to the rest of the industry. HIMS is outperformed by 69.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Altman-Z 2.59
ROIC/WACC0.67
WACC8.68%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 78.22% of the companies in the same industry.
  • HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.64
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for HIMS have decreased by -7.41% in the last year.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 51.33% on average over the next years. This is a very strong growth
  • HIMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.27% yearly.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%

3.3 Evolution

HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 31.64, HIMS can be considered very expensive at the moment.
  • HIMS's Price/Earnings is on the same level as the industry average.
  • HIMS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 27.21, which means the current valuation is very expensive for HIMS.
  • HIMS's Price/Forward Earnings ratio is in line with the industry average.
  • HIMS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.64
Fwd PE 27.21
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
  • HIMS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.14
EV/EBITDA 20.52
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
  • HIMS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as HIMS's earnings are expected to grow with 68.86% in the coming years.
PEG (NY)1.94
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS & HERS HEALTH INC

NYSE:HIMS (2/25/2026, 8:18:20 PM)

After market: 15.7299 -0.09 (-0.57%)

15.82

+0.36 (+2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners94.2%
Inst Owner Change-9.84%
Ins Owners5.93%
Ins Owner Change-1.34%
Market Cap3.60B
Revenue(TTM)N/A
Net Income(TTM)133.79M
Analysts67.27
Price Target30 (89.63%)
Short Float %37.45%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.29%
PT rev (3m)-11.57%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-32.54%
EPS NY rev (1m)0.73%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 31.64
Fwd PE 27.21
P/S 1.63
P/FCF 30.14
P/OCF 11.08
P/B 6.2
P/tB 28.4
EV/EBITDA 20.52
EPS(TTM)0.5
EY3.16%
EPS(NY)0.58
Fwd EY3.68%
FCF(TTM)0.52
FCFY3.32%
OCF(TTM)1.43
OCFY9.03%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)1.94
PEG (5Y)N/A
Graham Number5.36
Profitability
Industry RankSector Rank
ROA 5.99%
ROE 23.03%
ROCE 7.39%
ROIC 5.84%
ROICexc 9.03%
ROICexgc 14.91%
OM 5.96%
PM (TTM) 6.05%
GM 75.01%
FCFM 5.4%
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF 8.13
Debt/EBITDA 5.57
Cap/Depr 484.08%
Cap/Sales 9.3%
Interest Coverage 250
Cash Conversion 186.53%
Profit Quality 89.31%
Current Ratio 1.88
Quick Ratio 1.64
Altman-Z 2.59
F-Score3
WACC8.68%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.34%
EBIT Next 3Y88.26%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


What is the profitability of HIMS stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.


What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.